Suppr超能文献

链脲佐菌素诱导糖尿病的Wistar大鼠肾上腺中一氧化氮合酶和NADPH-黄递酶的增加及其被神经节苷脂的预防作用

Increase in nitric oxide synthase and NADPH-diaphorase in the adrenal gland of streptozotocin-diabetic Wistar rats and its prevention by ganglioside.

作者信息

Afework M, Lincoln J, Belai A, Burnstock G

机构信息

Department of Anatomy and Developmental Biology, University College London, U.K.

出版信息

Int J Dev Neurosci. 1996 Apr;14(2):111-23. doi: 10.1016/0736-5748(95)00091-7.

Abstract

Levels of nitric oxide synthase (NOS) and NADPH-diaphorase in adrenal glands of streptozotocin-diabetic rats of 8 and 12 weeks' duration compared with control rats were assessed with histo-chemical and biochemical techniques. Adrenal glands from streptozotocin-diabetic rats of 8 weeks' duration treated with ganglioside were examined also. In the adrenal medulla of 8-weeks- and 12-weeks-diabetic rats, NOS-immunoreactive nerve fibres were increased and decreased, respectively; additional NOS-immunoreactive and NADPH-diaphorase stained cells, which appeared to be cortical cells, were located in medulla and cortex compared with controls. Increased intensity in NADPH-diaphorase staining of the cortical cells of diabetic rats was observed also. Ganglioside treatment of the 8-weeks-diabetic rats prevented the diabetic-induced increase in NOS-immunoreactive nerve fibres. Also, it reduced most of the increase in the NOS-immunoreactive and NADPH-diaphorase stained cells and the intensity of NADPH-diaphorase staining of cortical cells. With biochemical assay, a significant increase in NOS activity was found in the adrenal glands from 8-weeks-diabetic rats, and this increase was reduced by ganglioside treatment in four out of six diabetic rats. In summary, streptozotocin-induced diabetes causes an initial increase in the levels of NOS and NADPH-diaphorase in the adrenal gland of rat, which was prevented by ganglioside treatment.

摘要

采用组织化学和生化技术,评估了病程8周和12周的链脲佐菌素诱导糖尿病大鼠肾上腺中一氧化氮合酶(NOS)和NADPH-黄递酶的水平,并与对照大鼠进行比较。还检查了用神经节苷脂治疗的病程8周的链脲佐菌素诱导糖尿病大鼠的肾上腺。在病程8周和12周的糖尿病大鼠肾上腺髓质中,NOS免疫反应性神经纤维分别增加和减少;与对照相比,在髓质和皮质中出现了额外的NOS免疫反应性和NADPH-黄递酶染色细胞,这些细胞似乎是皮质细胞。糖尿病大鼠皮质细胞的NADPH-黄递酶染色强度也增加。用神经节苷脂治疗病程8周的糖尿病大鼠可阻止糖尿病诱导的NOS免疫反应性神经纤维增加。此外,它还减少了大多数NOS免疫反应性和NADPH-黄递酶染色细胞的增加以及皮质细胞的NADPH-黄递酶染色强度。通过生化测定,发现病程8周的糖尿病大鼠肾上腺中NOS活性显著增加,在六只糖尿病大鼠中有四只,神经节苷脂治疗可降低这种增加。总之,链脲佐菌素诱导的糖尿病导致大鼠肾上腺中NOS和NADPH-黄递酶水平最初升高,而神经节苷脂治疗可阻止这种升高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验